Company intelligence / Profile preview

KYAN Therapeutics

Singapore, Singaporekyantechnologies.com ↗

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

KYAN Therapeutics develops and commercializes Optim.AI™, a functional precision medicine platform that empowers oncologists to personalize cancer treatment by testing patient-derived tumor samples against large panels of drugs and dose combinations. The technology integrates small data AI with biological experiments to efficiently identify optimal therapies tailored to each patient's unique tumor biology. The company’s approach has been validated in multiple peer-reviewed publications and implemented in several clinical studies. Their test has regulatory approval as a clinical laboratory service in Singapore.

Therapeutic areas: Oncology
Modalities: Small molecules (focus on drug-dose combinations in oncology)Ex vivo phenotypic screening
Industry: Digital Health Medical Devices

Partnerships

Collaborations with CellPhenomics GmbH and Alentis Therapeutics on combining their platforms for advanced oncology researchacademic collaborations with UCLA and National University of Singapore for technology development.

Beyond the preview

Go deeper on KYAN Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KYAN Therapeutics.

Explore the full profile